Biotest AG

Biotest AG Pfd.
Stock Exchange Xetra Stock Exchange
EPS
EUR3.88
Market Cap
EUR870.57 M
Shares Outstanding
19.79 M
Public Float
-
Biotest AG
Stock Exchange Xetra Stock Exchange
EPS
EUR3.88
Market Cap
EUR878.49 M
Shares Outstanding
19.79 M
Public Float
2 M

Profile

Address
Landsteinerstrasse 5
Dreieich Hessen 63303
Germany
Employees -
Website http://www.biotest.de
Updated 07/08/2019
Biotest AG engages in the development and distribution of biological and biotechnological pharmaceutical products. It focuses in the field of clinical immunology, haematology, and intensive care medicine. The company operates through the following segment: Therapy, Plasma & Services, and Other.

Financials

View All
Created with Highcharts 5.0.14Biotest AGNet Income. Fiscal year is January-December. All values EUR Thousands.32 00032 00019 20019 20027 00027 0006 0006 00016 40016 40012 90012 900201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Biotest AGSales/Revenue. Fiscal year is January-December. All values EUR Thousands.500 800500 800582 000582 000534 600534 600408 000408 000378 100378 100400 300400 3002013201420152016201720180100k200k300k400k500k600k700k

Rolf K. Hoffmann
Chairman-Supervisory Board
Christine Kreidl
Member-Supervisory Board